Literature DB >> 8911648

The immune effects of neuropeptides.

I Berczi1, I M Chalmers, E Nagy, R J Warrington.   

Abstract

Current evidence indicates that the neuroendocrine system is the highest regulator of immune/inflammatory reactions. Prolactin and growth hormone stimulate the production of leukocytes, including lymphocytes, and maintain immunocompetence. The hypothalamus-pituitary-adrenal axis constitutes the most powerful circuit regulating the immune system. The neuropeptides constituting this axis, namely corticotrophin releasing factor, adrenocorticotrophic hormone, alpha-melanocyte stimulating hormone, and beta-endorphin are powerful immunoregulators, which have a direct regulatory effect on lymphoid cells, regulating immune reactions by the stimulation of immunoregulatory hormones (glucocorticoids) and also by acting on the central nervous system which in turn generates immunoregulatory nerve impulses. Peptidergic nerves are major regulators of the inflammatory response. Substance P and calcitonin gene-related peptide are pro-inflammatory mediators and somatostatin is anti-inflammatory. The neuroendocrine regulation of the inflammatory response is of major significance from the point of view of immune homeostasis. Malfunction of this circuit leads to disease and often is life-threatening. The immune system emits signals towards the neuroendocrine system by cytokine mediators which reach significant blood levels (cytokine-hormones) during systemic immune/inflammatory reactions. Interleukin-1, -6, and TNF-alpha are the major cytokine hormones mediating the acute phase response. These cytokines induce profound neuroendocrine and metabolic changes by interacting with the central nervous system and with many other organs and tissues in the body. Corticotrophin releasing factor functions under these conditions as a major co-ordinator of the response and is responsible for activating the ACTH-adrenal axis for regulating fever and for other CNS effects leading to a sympathetic outflow. Increased ACTH secretion leads to glucocorticoid production. alpha-melanocyte stimulating hormone functions under these conditions as a cytokine antagonist and an anti-pyretic hormone. The sympathetic outflow, in conjunction with increased adrenal activity. leads to the elevation of catecholamines in the bloodstream and in tissues. Current evidence suggests that neuroimmune mechanisms are essential in normal physiology, such as tissue turnover, involution, atrophy, intestinal function, and reproduction. Host defence against infection, trauma and shock relies heavily on the neuroimmunoregulatory network. Moreover, abnormalities of neuroimmunoregulation contribute to the aetiology of autoimmune disease, chronic inflammatory disease, immunodeficiency, allergy, and asthma. Finally, neuroimmune mechanisms play an important role in regeneration and healing.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8911648     DOI: 10.1016/s0950-3579(96)80016-1

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  16 in total

Review 1.  Neuroimmune mechanisms in health and disease: 1. Health.

Authors:  H Anisman; M G Baines; I Berczi; C N Bernstein; M G Blennerhassett; R M Gorczynski; A H Greenberg; F T Kisil; R D Mathison; E Nagy; D M Nance; M H Perdue; D K Pomerantz; E R Sabbadini; A Stanisz; R J Warrington
Journal:  CMAJ       Date:  1996-10-01       Impact factor: 8.262

2.  Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.

Authors:  R A Tripp; D Moore; J Winter; L J Anderson
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Bromocriptine restores tolerance in estrogen-treated mice.

Authors:  E Peeva; C Grimaldi; L Spatz; B Diamond
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 4.  Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there?

Authors:  Antonella Fioravanti; Luca Cantarini; Giacomo Maria Guidelli; Mauro Galeazzi
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

Review 5.  T-Cells and excitotoxicity: HIV-1 and other neurodegenerative disorders.

Authors:  Muhammad Mukhtar; Edward Acheampong; Zahida Parveen; Roger J Pomerantz
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 6.  Balneotherapy in chronic inflammatory rheumatic diseases-a narrative review.

Authors:  Franco Cozzi; Luca Ciprian; Maria Carrara; Paola Galozzi; Elisabetta Zanatta; Anna Scanu; Paolo Sfriso; Leonardo Punzi
Journal:  Int J Biometeorol       Date:  2018-10-01       Impact factor: 3.787

7.  Low cortisol levels in active juvenile idiopathic arthritis.

Authors:  Yelda Bilginer; Rezan Topaloglu; Ayfer Alikasifoglu; Nazli Kara; Nesrin Besbas; Seza Ozen; Aysin Bakkaloglu
Journal:  Clin Rheumatol       Date:  2009-12-15       Impact factor: 2.980

8.  Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.

Authors:  Lia M Haynes; Joelyn Tonkin; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 9.  Inflammation and neuropeptides: the connection in diabetic wound healing.

Authors:  Leena Pradhan; Christoph Nabzdyk; Nicholas D Andersen; Frank W LoGerfo; Aristidis Veves
Journal:  Expert Rev Mol Med       Date:  2009-01-13       Impact factor: 5.600

10.  Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.

Authors:  Prema Robinson; A Clinton White; Dorothy E Lewis; John Thornby; Elliott David; Joel Weinstock
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.